Cargando…

Evaluating the safety and efficacy of dextromethorphan/quinidine in the treatment of pseudobulbar affect

Pseudobulbar affect (PBA) is a common manifestation of brain pathology associated with many neurological diseases, including amyotrophic lateral sclerosis, Alzheimer’s disease, stroke, multiple sclerosis, Parkinson’s disease, and traumatic brain injury. PBA is defined by involuntary and uncontrollab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schoedel, Kerri A, Morrow, Sarah A, Sellers, Edward M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4079824/ https://www.ncbi.nlm.nih.gov/pubmed/25061302 http://dx.doi.org/10.2147/NDT.S30713

Ejemplares similares

Review of Dextromethorphan 20 mg/Quinidine 10 mg (NUEDEXTA(®)) for Pseudobulbar Affect
por: Pioro, Erik P.
Publicado: (2014)

A Study of Potential Pharmacokinetic and Pharmacodynamic Interactions between Dextromethorphan/Quinidine and Memantine in Healthy Volunteers
por: Pope, Laura E., et al.
Publicado: (2012)

Treatment of pseudobulbar affect in a mixed neurodegenerative disorder with compounded quinidine capsules and dextromethorphan cough syrup
por: Villeneuve, Yannick, et al.
Publicado: (2020)

An open-label multicenter study to assess the safety of dextromethorphan/quinidine in patients with pseudobulbar affect associated with a range of underlying neurological conditions
por: Pattee, Gary L., et al.
Publicado: (2014)

PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury
por: Hammond, Flora M., et al.
Publicado: (2016)

Erratum to: PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury
por: Hammond, Flora M., et al.
Publicado: (2016)

Evidence for using dextromethorphan-quinidine for the treatment of agitation in dementia
por: Tampi, Rajesh R, et al.
Publicado: (2020)

Deuterated dextromethorphan/quinidine for agitation in Alzheimer's disease
por: Khoury, Rita
Publicado: (2021)

Dextromethorphan/quinidine for the treatment of bulbar impairment in amyotrophic lateral sclerosis
por: Tabor Gray, Lauren, et al.
Publicado: (2023)

Pseudobulbar affect: prevalence and management
por: Ahmed, Aiesha, et al.
Publicado: (2013)

Pseudobulbar Affect Presenting as Hypomania
por: Espiridion, Eduardo D, et al.
Publicado: (2020)

Diagnosing pseudobulbar affect in traumatic brain injury
por: Engelman, William, et al.
Publicado: (2014)

Pseudobulbar Affect in Parkinsonian Disorders: A Review
por: Hakimi, Mathew, et al.
Publicado: (2019)

Pseudobulbar Affect Presenting as Aggressive Behavior
por: Kazi, Sana Elham, et al.
Publicado: (2022)

Additional evidence for a therapeutic effect of dextromethorphan/quinidine on bulbar motor function in patients with amyotrophic lateral sclerosis: A quantitative speech analysis
por: Green, Jordan R., et al.
Publicado: (2018)

Persistent pseudobulbar affect secondary to acute disseminated encephalomyelitis
por: Li, Zhendong, et al.
Publicado: (2015)

Pseudobulbar Affect Mimicking Depression: A Case Report
por: Kekere, Victor, et al.
Publicado: (2022)

Pseudobulbar affect as an early manifestation of HIV-related toxoplasmosis
por: Arbelo, N., et al.
Publicado: (2022)

Therapeutic Approach of a High Functioning Individual With Traumatic Brain Injury and Subsequent Emotional Volatility With Features of Pathological Laughter and Crying With Dextromethorphan/Quinidine
por: Garcia-Baran, Dynela, et al.
Publicado: (2016)

Antipsychotic Drugs Efficacy in Dextromethorphan-Induced Psychosis
por: Zaremba, Malgorzata, et al.
Publicado: (2023)

The Price of Quinidine
Publicado: (1922)

Neurocysticercosis presenting as pseudobulbar palsy
por: Kumar, Arinaganahalli Subbanna Praveen, et al.
Publicado: (2014)

A Major Depressive Disorder in a Patient with Pseudobulbar Affect
por: Espiridion, Eduardo D, et al.
Publicado: (2018)

Neuronal Dysregulation in Stroke-Associated Pseudobulbar Affect (PBA): Diagnostic Scales and Current Treatment Options
por: Lapchak, Paul A
Publicado: (2015)

Prevalence of pseudobulbar affect symptoms and clinical correlates in nursing home residents
por: Foley, Kevin, et al.
Publicado: (2015)

Prevalence of Pseudobulbar Affect (PBA) in Parkinson’s Disease: An Underrecognized Patient Burden
por: Falconer, Ramsey, et al.
Publicado: (2021)

Dextromethorphan-bupropion (Auvelity) for the Treatment of Major Depressive Disorder
por: McCarthy, Brian, et al.
Publicado: (2023)

Living With the Burden of Pseudobulbar Affect: A Qualitative Analysis of the Effects of Education on Patient Experience
por: Turell, Wendy, et al.
Publicado: (2020)

A Unique Case of Valacyclovir Toxicity and Pseudobulbar Affect in a Patient On Peritoneal Dialysis
por: Memon, Waqas, et al.
Publicado: (2021)

Emotional Incontinence: A Case Report of Pseudobulbar Affect in the Setting of Alcohol Use Disorder
por: Nwabueze, Christian, et al.
Publicado: (2023)

Quinidine for Brugada syndrome: Panacea or poison?
por: Hai, Jo-Jo, et al.
Publicado: (2016)

Concurrent Quinidine and Phenobarbital in the Treatment of a Patient with 2 KCNT1 Mutations
por: Passey, Camerin C., et al.
Publicado: (2019)

Anti-Yo Mediated Paraneoplastic Cerebellar Degeneration Associated with Pseudobulbar Affect in a Patient with Breast Cancer
por: Martin, Allison N., et al.
Publicado: (2017)

A pilot study of quinidine and epirubicin in the treatment of advanced breast cancer.
por: Jones, R. D., et al.
Publicado: (1990)

Effects of dextromethorphan and oxycodone on treatment of neuropathic pain in mice
por: Yang, Pao-Pao, et al.
Publicado: (2015)

PRISM: A Novel Research Tool to Assess the Prevalence of Pseudobulbar Affect Symptoms across Neurological Conditions
por: Brooks, Benjamin Rix, et al.
Publicado: (2013)

The Therapeutic Value of Quinidine Sulphate in Auricular Fibrillation
por: Ritchie, W. T.
Publicado: (1922)

Evaluation of the neuroprotective effect of dextromethorphan in the acute phase of ischaemic stroke
por: Mousavi, Seyed Ali, et al.
Publicado: (2011)

Beneficial Effects of Isoproterenol and Quinidine in the Treatment of Ventricular Fibrillation in Brugada Syndrome
por: Dakkak, Melissa, et al.
Publicado: (2015)

Evaluation of dextromethorphan with select antidepressant therapy for the treatment of depression in the acute care psychiatric setting
por: Nofziger, Jill L., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lhhs2bcnbfdmol36vmpjsijsuk